6ER-017 Prevention of extravasation by the local application of hybrid aerogel microparticles as drug delivery systems for cervical cancer chemotherapy
6ER-017 Prevention of extravasation by the local application of hybrid aerogel microparticles as drug delivery systems for cervical cancer chemotherapy